PBI ANDAs
Executive Summary
PBI ANDAs: Denver, Colorado-based Pharmaceutical Basics Inc. received 29 ANDA approvals for 12 different chemical entities in 1987, making it the third most effective generic firm in generating ANDA approvals for the year. "The Pink Sheet" (Feb. 1, p. 6) counted Colmed Labs and PBI ANDA approvals separately. Colmed and PBI were merged in July 1986, when Akzo acquired them.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.